Rosuvastatin sodium
CAS: 147098-18-8
Ref. 3D-FR33470
1g | 191,00 € | ||
2g | 286,00 € | ||
5g | 403,00 € | ||
10g | 478,00 € | ||
500mg | 135,00 € |
Produktinformation
- 7-{4-(4-Fluorophenyl)-6-Isopropyl-2-[Methyl(Methylsulfonyl)Amino]Pyrimidin-5-Yl}-3,5-Dihydroxyhept-6-Enoic Acid
- Crestor
- Rosuvastatin Ca
- Rosuvastatin, Calcium Salt
- 7-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-(N-methyl-N-methylsulfonyl-amino)-pyrimidin-5-yl]-3,5-dihydroxy-hept-6-enoic acid sodium salt
- calcium bis[(3R,5S,6E)-7-{4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoate]
- calcium bis{(6E)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoate}
Rosuvastatin sodium salt is a statin drug that inhibits the enzyme HMG-CoA reductase. It is used to lower cholesterol and triglyceride levels in the blood, and to prevent heart attacks and strokes. Rosuvastatin sodium salt has been shown to have anti-inflammatory activity in human liver cells, which may be due to its ability to suppress the release of proinflammatory cytokines. Rosuvastatin sodium salt has also been shown to have synergistic effects with other drugs such as desipramine hydrochloride in primary cells, which may be due to its ability to inhibit the activity of cytochrome P450 enzymes. This drug is metabolized by alkali hydrolysis into rosuvastatin acid, which is then converted into an active form by polymorphic esterases in the liver. The active form can then be hydrolyzed by plasma esterases into inactive metabolites.
Rosuvastatin sodium salt is a crystalline powder
Chemische Eigenschaften
Technische Anfrage zu: 3D-FR33470 Rosuvastatin sodium
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.